The price of the Indian version of Pitobrutinib/Pitobrutinib is very high, so you don’t have to worry about it when buying drugs overseas!

Pirtobrutinib is a selective Bruton's tyrosine kinase (BTK) inhibitor mainly used to treat relapsed or refractory mantle cell lymphoma (MCL) and chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL). Although there is no definite information in the Indian market that local pharmaceutical companies have begun producing generic versions of the drug, India, as an important pharmaceutical market, usually has a variety of treatment options for patients to choose from.

Currently, whether patients can obtain pitobrutinib and its price in India mainly depend on the supply of imported drugs. Based on market feedback, many overseas countries and regions have launched generic versions of pitobrutinib. For example, a Lao pharmaceutical factory produces generic Pitobrutinib with a specification of 50mg and 30 tablets per box, and its price is about more than 2,000 yuan. This price is subject to change due to factors such as exchange rate fluctuations and shipping costs.

In India, due to the strength and flexibility of its pharmaceutical industry, access to medicines may include direct import from international pharmaceutical suppliers or purchase through online pharmacies. Although there is no specific local manufacturer yet, as market demand increases, more generic drugs may enter the market in the future. In addition, since India has a strong drug regulatory system, patients need to ensure that the source is formal when purchasing drugs to avoid encountering products of substandard quality.

It can be seen that although there is currently no clear generic supplier of pitobrutinib in the Indian market, patients still have the opportunity to obtain the drug through other channels. Against the background of gradually improving medical security policies, the market for pitobrutinib may also become more diverse in the future with the introduction of more treatment options.

Reference materials:https://go.drugbank.com/drugs/DB17472